+(91-22) 61772000 (25 Lines)
   |   GST ID : 27AAECS6989F1ZS
   |   CIN : U72200MH2000PTC125470

Solvay builds new Epichlorohydrin plant to meet growing demand with innovative production process

Petrochemical industry | 02 Jan 2006 IST | Polymerupdate.com
A strategic outlet for booming ‘green’ biodiesel industry

Embargo: January 31, 2006 at 8:30 AM (Brussels Time): Solvay announces that it will build a new epichlorohydrin plant on its industrial site of Tavaux, France, implementing a novel process with greatly enhanced environmental performance. The process, called Epicerol, was successfully developed by Solvay’s R&D and is based on the transformation of glycerine, a by-product of the biodiesel industry. The new plant, which is scheduled to be operational by the first half of 2007, will be fed with glycerine derived from rapeseed oil and fits perfectly with the development of the Biodiesel industry actively supported by the French government.

The development of the glycerine-based process for the production of epichlorohydrin is covered by eleven patent applications issued by Solvay.

The steadily increasing demand for epichlorohydrin – whose main applications include the production of epoxy resins, paper reinforcement and water purification – is expected to exceed the existing global production capacity by 2010. Solvay has secured a long-term contract for the supply of glycerine with French company Diester Industrie, capitalizing on the fast growth of the biofuels industry and the large quantities of glycerine available at an appropriate price. The new plant will have an initial production capacity of 10 kilotons per annum and could be quickly duplicated to respond to the rapid market growth.

In the Epicerol process, glycerine – a renewable material – is substituted for propylene, a hydrocarbon. Other environmental benefits include reduction of chlorinated by-products and sharp reduction of water consumption.

“The industrialization of the Epicerol process illustrates the implementation of Solvay’s strategy to ensure sustainable, profitable growth through innovation,” commented Freddy Gielen, managing director of the strategic business unit Electrochemistry and Derived Specialties. “The combination of our R&D with the new opportunities arising from the ‘green’ chemical and fuel industry gives us the opportunity to optimize the process, making it eventually both economical and environmentally friendly,” he added.

SOLVAY is an international chemicals and pharmaceuticals group with headquarters in Brussels. It is present in more than 50 countries and employs some 33,000 people in its Chemicals, Plastics and Pharmaceuticals activities. Including the recently acquired Fournier Pharma, its 2004 sales amounted to EUR 8.5 billion. Solvay is listed on the Euronext 100 index of top European companies. Details are available at www.solvay.com.
Note: This story has not been edited by The Polymerupdate Editorial team and is auto-generated from a syndicated feed.

Polymerupdate perpetual and fresh feed of latest happenings in the Petrochemical and Polymer Industry is presented through the Press Releases section, which help our clients to gain a good sense of the current trade environment. This information is instrumental for future strategies.

back to list